Author
Listed:
- Lakshmanan Ganesh
(Vaccine Research Center, NIAID, National Institutes of Health)
- Ezra Burstein
(Vaccine Research Center, NIAID, National Institutes of Health
University of Michigan, Medical Science I)
- Anuradha Guha-Niyogi
(Vaccine Research Center, NIAID, National Institutes of Health)
- Mark K. Louder
(Vaccine Research Center, NIAID, National Institutes of Health)
- John R. Mascola
(Vaccine Research Center, NIAID, National Institutes of Health)
- Leo W. J. Klomp
(University Medical Center Utrecht)
- Cisca Wijmenga
(University Medical Center Utrecht)
- Colin S. Duckett
(University of Michigan, Medical Science I)
- Gary J. Nabel
(Vaccine Research Center, NIAID, National Institutes of Health)
Abstract
Although human immunodeficiency virus-1 (HIV-1) infects quiescent and proliferating CD4+ lymphocytes, the virus replicates poorly in resting T cells1,2,3,4,5,6. Factors that block viral replication in these cells might help to prolong the asymptomatic phase of HIV infection7; however, the molecular mechanisms that control this process are not fully understood. Here we show that Murr1, a gene product known previously for its involvement in copper regulation8,9, inhibits HIV-1 growth in unstimulated CD4+ T cells. This inhibition was mediated in part through its ability to inhibit basal and cytokine-stimulated nuclear factor (NF)-κB activity. Knockdown of Murr1 increased NF-κB activity and decreased IκB-α concentrations by facilitating phospho-IκB-α degradation by the proteasome. Murr1 was detected in CD4+ T cells, and RNA-mediated interference of Murr1 in primary resting CD4+ lymphocytes increased HIV-1 replication. Through its effects on the proteasome, Murr1 acts as a genetic restriction factor that inhibits HIV-1 replication in lymphocytes, which could contribute to the regulation of asymptomatic HIV infection and the progression of AIDS.
Suggested Citation
Lakshmanan Ganesh & Ezra Burstein & Anuradha Guha-Niyogi & Mark K. Louder & John R. Mascola & Leo W. J. Klomp & Cisca Wijmenga & Colin S. Duckett & Gary J. Nabel, 2003.
"The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes,"
Nature, Nature, vol. 426(6968), pages 853-857, December.
Handle:
RePEc:nat:nature:v:426:y:2003:i:6968:d:10.1038_nature02171
DOI: 10.1038/nature02171
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:426:y:2003:i:6968:d:10.1038_nature02171. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.